Vontobel Holding Ltd. Increases Stock Holdings in Agilent Technologies, Inc. $A

Vontobel Holding Ltd. raised its stake in Agilent Technologies, Inc. (NYSE:A) by 12.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 21,916 shares of the medical research company’s stock after purchasing an additional 2,472 shares during the quarter. Vontobel Holding Ltd.’s holdings in Agilent Technologies were worth $2,586,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the stock. Maryland State Retirement & Pension System lifted its holdings in shares of Agilent Technologies by 3.2% during the second quarter. Maryland State Retirement & Pension System now owns 13,849 shares of the medical research company’s stock worth $1,634,000 after purchasing an additional 425 shares during the period. Sitrin Capital Management LLC raised its position in Agilent Technologies by 34.3% during the 2nd quarter. Sitrin Capital Management LLC now owns 47,356 shares of the medical research company’s stock worth $5,588,000 after buying an additional 12,097 shares during the last quarter. Dohj LLC increased its stake in shares of Agilent Technologies by 12.6% during the second quarter. Dohj LLC now owns 6,581 shares of the medical research company’s stock worth $777,000 after acquiring an additional 738 shares during the period. Shell Asset Management Co. increased its stake in shares of Agilent Technologies by 6.5% during the second quarter. Shell Asset Management Co. now owns 20,772 shares of the medical research company’s stock worth $2,451,000 after acquiring an additional 1,271 shares during the period. Finally, Godsey & Gibb Inc. increased its stake in shares of Agilent Technologies by 19.8% during the second quarter. Godsey & Gibb Inc. now owns 166,664 shares of the medical research company’s stock worth $19,668,000 after acquiring an additional 27,520 shares during the period.

Analyst Ratings Changes

A number of brokerages have weighed in on A. Rothschild & Co Redburn began coverage on Agilent Technologies in a report on Wednesday. They issued a “buy” rating and a $165.00 price objective on the stock. Barclays increased their price objective on Agilent Technologies from $125.00 to $150.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 2nd. Robert W. Baird increased their price objective on Agilent Technologies from $141.00 to $142.00 and gave the stock an “outperform” rating in a research report on Thursday, August 28th. Wall Street Zen raised shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Friday, October 3rd. Finally, Rothschild Redb raised shares of Agilent Technologies to a “strong-buy” rating in a research note on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, Agilent Technologies presently has an average rating of “Moderate Buy” and an average target price of $148.69.

Agilent Technologies Stock Down 2.5%

Agilent Technologies stock opened at $136.62 on Friday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.71 and a current ratio of 2.25. The firm has a market capitalization of $38.73 billion, a price-to-earnings ratio of 32.07, a price-to-earnings-growth ratio of 4.46 and a beta of 1.26. Agilent Technologies, Inc. has a fifty-two week low of $96.43 and a fifty-two week high of $153.84. The stock’s fifty day moving average is $125.04 and its two-hundred day moving average is $117.03.

Agilent Technologies (NYSE:A) last released its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 EPS for the quarter, hitting the consensus estimate of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period in the previous year, the firm earned $1.32 EPS. The business’s revenue for the quarter was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 22nd. Stockholders of record on Tuesday, September 30th will be paid a dividend of $0.248 per share. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies’s dividend payout ratio (DPR) is 23.24%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.